Multimodal approaches to improve immunotherapy in breast cancer
Multimodal approaches to improve immunotherapy in breast cancer
About this item
Full title
Author / Creator
Publisher
London: Future Medicine Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: Future Medicine Ltd
Subjects
More information
Scope and Contents
Contents
Multiple ongoing clinical trials are investigating the therapeutic efficacy of the HER2-DC1 vaccine in the receptor positive primary and MBC landscape (NCT03384914 and NCT03112590).Additionally, a combination of HER2-DC1 vaccine with HER2 targeted therapy and checkpoint blockade significantly delayed tumor burden and improved survival in a preclini...
Alternative Titles
Full title
Multimodal approaches to improve immunotherapy in breast cancer
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2501456708
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2501456708
Other Identifiers
ISSN
1750-743X
E-ISSN
1750-7448
DOI
10.2217/imt-2019-0198
